Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary

References

• Abdollahi M, Rahmat-Jirdeh N, Soltaninejad K. (2001). Protection by selenium of lead-acetate-induced alterations on rat submandibular gland function. Hum Exp Toxicol 20:28–33
   PubMed Web of Science ®Google Scholar
• Abedelahi A, Salehnia M, Allameh AA, Davoodi D. (2010). Sodium selenite improves the in vitro follicular development by reducing the reactive oxygen species level and increasing the total antioxidant capacity and glutathione peroxide activity. Hum Reprod 25:977–85
   PubMed Web of Science ®Google Scholar
• Arab HH, El-Sawalhi MM. (2013). Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: Modulation of oxidative stress and inflammatory mediators. Toxicol Appl Pharmacol 268:241–8
   PubMed Web of Science ®Google Scholar
• Balen AH, Rutherford AJ. (2007). Managing anovulatory infertility and polycystic ovary syndrome. Br Med J 335:663–6
   PubMed Web of Science ®Google Scholar
• Barria A, Leyton V, Ojeda SR, Lara HE. (1993). Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: Role of sympathetic innervation. Endocrinology 133:2696–703
   PubMed Web of Science ®Google Scholar
• Barrington JW, Lindsay P, James D, et al. (1996). Selenium deficiency and miscarriage: A possible link? Br J Obstet Gynaecol 103:130–2
   PubMedGoogle Scholar
• Basini G, Tamanini C. (2000). Selenium stimulates estradiol production in bovine granulosa cells: Possible involvement of nitric oxide. Domest Anim Endocrinol 18:1–17
   PubMed Web of Science ®Google Scholar
• Belgorosky D, Sander VA, Yorio MP, et al. (2010). Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice. Reprod Biomed Online 20:797–807
   PubMed Web of Science ®Google Scholar
• Bhatt P, Makwana D, Santani D, Goyal R. (2007). Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with l-thyroxin-induced hyperthyroidism-an experimental study. Can J Physiol Pharmacol 85:514–20
   PubMed Web of Science ®Google Scholar
• Boshra V, El Wakeel GA. (2013). The potential effect of carvedilol against osteoporosis in ovariectomized rats. Curr Drug Therapy 8:164–70
   Google Scholar
• Brozmanová J, Mániková D, Vlčková V, Chovanec M. (2010). Selenium: A double-edged sword for defense and offence in cancer. Arch Toxicol 84:919–38
   PubMed Web of Science ®Google Scholar
• Dandona P1, Ghanim H, Brooks DP. (2007). Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 25:731–41
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Richards JS. (2013). Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril 100:23–38
   PubMed Web of Science ®Google Scholar
• Duntas LH. (2009). Selenium and inflammation: Underlying anti-inflammatory mechanisms. Horm Metab Res 41:443–7
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Luque-Ramírez M, González F. (2011). Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis. Fertil Steril 95:1048–58
   PubMed Web of Science ®Google Scholar
• Fernandois D, Lara HE, Paredes AH. (2012). Blocking of β-adrenergic receptors during the subfertile period inhibits spontaneous ovarian cyst formation in rats. Horm Metab Res 44:682–7
   PubMed Web of Science ®Google Scholar
• Fonarow GC. (2009). Role of carvedilol controlled-release in cardiovascular disease. Expert Rev Cardiovasc Ther 7:483–98
   PubMedGoogle Scholar
• Ghanbari S, Yonessi M, Mohammadirad A, et al. (2012). Effects of IMOD and Angipars™on mouse d-galactose-induced model of aging. Daru 20:68--75
   Web of Science ®Google Scholar
• González F. (2012). Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction. Steroids 77:300–5
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. (2011). Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219–31
   PubMed Web of Science ®Google Scholar
• Hakucho A1, Liu J, Liu X, Fujimiya T. (2014). Carvedilol improves ethanol-induced liver injury via modifying the interaction between oxidative stress and sympathetic hyperactivity in rats. Hepatol Res 44:560–70
   PubMed Web of Science ®Google Scholar
• Harrison JH, Hancock DD, Conrad HR. (1984). Vitamin E and selenium for reproduction of the dairy cow. J Dairy Sci 67:123–32
   PubMed Web of Science ®Google Scholar
• Hasani-Ranjbar S, Larijani B, Abdollahi M. (2009). A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 8:2–10
   PubMedGoogle Scholar
• Hosseini-Tabatabaei A, Esmaily H, Rahimian R, et al. (2009). Benefit of nicorandil using an immunologic murine model of experimental colitis. Cent Eur J Biol 4:74–85
   Web of Science ®Google Scholar
• Huang H, Shan J, Pan XH, et al. (2007). Carvedilol improved diabetic rat cardiac function depending on antioxidant ability. Diabetes Res Clin Pract 75:7–13
   PubMed Web of Science ®Google Scholar
• Johansson J, Stener-Victorin E. (2013). Polycystic ovary syndrome: Effect and mechanisms of acupuncture for ovulation induction. Evid-Based Complement Alternat Med 2013:762615
   PubMed Web of Science ®Google Scholar
• Jonard S, Dewailly D. (2004). The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10:107–17
   PubMed Web of Science ®Google Scholar
• Joukar S, Najafipour H, Mirzaeipour F, et al. (2013). Modulatory effect of semelil (Angipars) on isoproterenol induced cardiac injury. EXCLI J 12:122–9
   PubMed Web of Science ®Google Scholar
• Kamada H, Hodate K. (1998). Effect of dietary selenium supplementation on the plasma progesterone concentration in cows. J Vet Med Sci 60:133–5
   PubMed Web of Science ®Google Scholar
• Kamada H, Ikumo H. (1997). Effect of selenium on cultured bovine luteal cells. Anim Reprod Sci 46:203–11
   PubMed Web of Science ®Google Scholar
• Kveiborg B, Christiansen B, Major-Petersen A, Torp-Pedersen C. (2006). Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs 6:209–17
   PubMedGoogle Scholar
• Larijani B, Afshari M, Astanehi-Asghari F, et al. (2006). Effect of short-term carvedilol therapy on salivary and plasma oxidative stress parameters and plasma glucose level in type II diabetes. Therapy 3:119–23
   Google Scholar
• Larijani B, Heshmat R, Bahrami A, et al. (2008). Effects of intravenous Semelil (ANGIPARSTM) on diabetic foot ulcers healing: A multicenter clinical trial. Daru 16:35–40
   Google Scholar
• Lewandowski KC, Komorowski J, O'Callaghan CJ, et al. (2006). Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 91:1173–7
   PubMed Web of Science ®Google Scholar
• Luna SL, Neuman S, Aguilera J, et al. (2012). In vivo β-adrenergic blockade by propranolol prevents isoproterenol-induced polycystic ovary in adult rats. Horm Metab Res 44:676–81
   PubMed Web of Science ®Google Scholar
• Lysko PG, Webb CL, Gu JL, et al. (2000). A comparison of carvedilol and metoprolol antioxidant activities in vitro. J Cardiovasc Pharmacol 36:277–81
   PubMed Web of Science ®Google Scholar
• Meenakumari KJ, Agarwal S, Krishna A, Pandey LK. (2004). Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome. Braz J Med Biol Res 37:1637–44
   PubMed Web of Science ®Google Scholar
• Mizuochi Y, Okajima K, Harada N, et al. (2007). Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Transl Res 149:223–30
   PubMed Web of Science ®Google Scholar
• Moran LJ, Misso ML, Wild RA, Norman RJ. (2010). Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update 16:347–63
   PubMed Web of Science ®Google Scholar
• Mousavi-Jazi M, Aslroosta H, Moayer AR, et al. (2010). Effects of Angipars™ on oxidative inflammatory indices in a murine model of periodontitis. Daru 18:260–4
   Google Scholar
• Mukherjee S, Maitra A. (2010). Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res 131:743–60
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. (2013). Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Hum Reprod Update 19:268–88
   PubMed Web of Science ®Google Scholar
• Oettl K, Greilberger J, Zangger K, et al. (2001). Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol 15:241–8
   Web of Science ®Google Scholar
• Ogunro PS, Ogungbamigbe TO, Elemie PO, et al. (2006). Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: A correlation with the disease progression. Niger Postgrad Med J 13:1–5
   PubMedGoogle Scholar
• Ohtsuka T, Hamada M, Saeki H, et al. (2003). Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels. Am J Cardiol 15:1024–7
   Web of Science ®Google Scholar
• Ouyang Y, Chen Z, Tan M, et al. (2013). Carvedilol, a third-generation β-blocker prevents oxidative stress-induced neuronal death and activates Nrf2/ARE pathway in HT22 cells. Biochem Biophys Res Commun 29:917–22
   Web of Science ®Google Scholar
• Pakzad M, Fouladdel S, Nili-Ahmadabadi A, et al. (2013). Sublethal exposures of diazinon alters glucose homostasis in Wistar rats; biochemical and molecular evidences of oxidative stress in adipose tissues. Pest Biochem Physiol 105:57–61
   PubMed Web of Science ®Google Scholar
• Pasquali R, Stener-Victorin E, Yildiz BO, et al. (2011). PCOS Forum: Research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) 74:424–33
   PubMed Web of Science ®Google Scholar
• Paszkowski T, Traub AI, Robinson SY, McMaster D. (1995). Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta 236:173–80
   PubMed Web of Science ®Google Scholar
• Pleşca-Manea L, Pârvu AE, Pârvu M, et al. (2002). Effects of Melilotus officinalis on acute inflammation. Phytother Res 16:316–19
   PubMed Web of Science ®Google Scholar
• Rezvanfar MA, Rezvanfar MA, Ahmadi A, et al. (2012a). Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: Biochemical and pathological evidences for beneficial effect of pioglitazone. Hum Exp Toxicol 31:887–97
   PubMed Web of Science ®Google Scholar
• Rezvanfar MA, Rezvanfar MA, Ahmadi A, et al. (2012b). Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary. Theriogenology 78:620–31
   PubMed Web of Science ®Google Scholar
• Rezvanfar MA, Saadat S, Shojaei Saadi HA, et al. (2015). Cellular and molecular mechanisms of pentoxifylline’s beneficial effects in experimental polycystic ovary. Theriogenology 83:968--77
   Google Scholar
• Rezvanfar MA, Shojaei Saadi HA, Gooshe M, et al. (2014). Ovarian aging like phenotype in the hyperandrogenism-induced murine model of polycystic ovary. Oxid Med Cell Longev 2014:948951
   PubMed Web of Science ®Google Scholar
• Rizzo A, Spedicato M, Mutinati M, et al. (2011). In vivo and in vitro studies of the role of the adrenergic system and follicular wall contractility in the pathogenesis and resolution of bovine follicular cysts. Theriogenology 76:1526–31
   PubMed Web of Science ®Google Scholar
• Rodrigues Ma1, Rodrigues JL, Martins NM, et al. (2011). Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem Biol Interact 189:45–51
   PubMed Web of Science ®Google Scholar
• Romana-Souza B, Santos JS, Monte-Alto-Costa A. (2009). b-1 And b-2, but not a-1 and a-2, adrenoceptro blockade delays rat cutaneous wound healing. Wound Rep Reg 17:230–9
   PubMed Web of Science ®Google Scholar
• Saeidnia S, Abdollahi M. (2013). Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol Appl Pharmacol 15:442–55
   Web of Science ®Google Scholar
• Sasson R, Winder N, Kees S, Amsterdam A. (2002). Induction of apoptosis in granulosa cells by TNF alpha and its attenuation by glucocorticoids involve modulation of Bcl-2. Biochem Biophys Res Commun 294:51–9
   PubMed Web of Science ®Google Scholar
• Showell M, Brown GJ, Clarke J, Hart RJ. (2013). Antioxidants for female subfertility. Cochrane Database Syst Rev 5:8, CD007807
   Google Scholar
• Singh D, Chander V, Chopra K. (2004). Carvedilol attenuates ischemia–reperfusion-induced oxidative renal injury in rats. Fundam Clin Pharmacol 18:627–34
   PubMed Web of Science ®Google Scholar
• Stafylas PC, Sarafidis PA. (2008). Carvedilol in hypertension treatment. Vasc Health Risk Manag 4:23–30
   PubMedGoogle Scholar
• Steinbrenner H, Sies H. (2009). Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta 1790:1478–85
   PubMed Web of Science ®Google Scholar
• Welt CK, Carmina E. (2013). Lifecycle of polycystic ovary syndrome (PCOS): From in utero to menopause. J Clin Endocrinol Metab 98:4629–38
   PubMed Web of Science ®Google Scholar
• Wichtel JJ. (1998). A review of selenium deficiency in grazing ruminants. Part 1: New roles for selenium in ruminant metabolism. N Z Vet J 46:47–52
   PubMed Web of Science ®Google Scholar
• Zepeda RJ, Castillo R, Rodrigo R, et al. (2012). Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension. Basic Clin Pharmacol Toxicol 111:309–16
   PubMed Web of Science ®Google Scholar